NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+33.26%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.84B
AUM Growth
+$1.84B
(+38%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
9.09%
Top 10 Holdings %
Top 10 Hldgs %
76.86%
Holding
43
New
2
Increased
2
Reduced
3
Closed
1
Top Buys
Top Sells
| 1 |
Senti Biosciences
SNTI
|
$9M |
| 2 |
TUYA
Tuya Inc
TUYA
|
$5.58M |
| 3 |
MYND
Mynd.ai
MYND
|
$2.75M |
| 4 |
AFMD
Affimed
AFMD
|
$3 |
Sector Composition
| 1 | Healthcare | 90.15% |
| 2 | Consumer Staples | 5.57% |
| 3 | Technology | 3.35% |
| 4 | Communication Services | 0.56% |
| 5 | Industrials | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$3.85B
| $313M | 17.04% | 3,745,262 | – | – |
|
|
TEM
2
Tempus AI, Inc. Class A Common Stock
TEM
$13.2B
| $305M | 16.61% | 5,385,979 +813,169 | +18% | +$46M |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $161M | 8.75% | 5,584,753 | – | – |
|
4
Rhythm Pharmaceuticals
RYTM
$6.85B
| $152M | 8.31% | 2,909,956 | – | – |
|
5
Savara
SVRA
$567M
| $104M | 5.65% | 24,471,264 | – | – |
|
6
Coursera
COUR
$1.88B
| $102M | 5.57% | 12,867,769 | – | – |
|
|
MBX
7
MBX Biosciences, Inc. Common Stock
MBX
$507M
| $93.9M | 5.12% | +3,614,486 | New | +$93.9M |
|
8
CRISPR Therapeutics
CRSP
$4.71B
| $74.6M | 4.06% | 1,587,854 | – | – |
|
9
NextNav
NN
$2.37B
| $61.3M | 3.34% | 8,189,156 | – | – |
|
|
ZBIO
10
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $44.2M | 2.41% | +2,613,948 | New | +$44.2M |
|
11
Monte Rosa Therapeutics
GLUE
$296M
| $40.8M | 2.22% | 7,692,298 | – | – |
|
12
Trevi Therapeutics
TRVI
$883M
| $38M | 2.07% | 11,370,376 | – | – |
|
13
Korro Bio
KRRO
$217M
| $36.5M | 1.99% | 1,090,793 | – | – |
|
14
Phathom Pharmaceuticals
PHAT
$864M
| $35.4M | 1.93% | 1,960,169 | – | – |
|
15
Aurinia Pharmaceuticals
AUPH
$1.58B
| $29.1M | 1.59% | 3,969,834 | – | – |
|
16
CVRx
CVRX
$205M
| $20.9M | 1.14% | 2,370,542 | – | – |
|
17
Black Diamond Therapeutics
BDTX
$157M
| $19.4M | 1.05% | 4,448,757 | – | – |
|
18
Celcuity
CELC
$2.17B
| $18.6M | 1.02% | 1,250,001 | – | – |
|
19
Gossamer Bio
GOSS
$562M
| $17.9M | 0.98% | 18,093,034 | – | – |
|
|
ADAP
20
Adaptimmune Therapeutics
ADAP
$15.6M
| $16.2M | 0.88% | 17,079,778 | – | – |
|
21
Nkarta
NKTX
$151M
| $16.1M | 0.88% | 3,568,781 | – | – |
|
22
Oric Pharmaceuticals
ORIC
$994M
| $15.4M | 0.84% | 1,500,000 | – | – |
|
23
NeueHealth
NEUE
$59.2M
| $14.2M | 0.78% | 2,726,917 | – | – |
|
|
INZY
24
DELISTED
Inozyme Pharma
INZY
| $12.7M | 0.69% | 2,437,689 | – | – |
|
25
Geron
GERN
$893M
| $12.6M | 0.69% | 2,776,409 | – | – |
|